SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and life-threatening. Virus-neutralizing monoclonal antibodies are predicted to reduce viral load, ameliorate symptoms, and prevent hos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Chen, Peter, Nirula, Ajay, Heller, Barry, Gottlieb, Robert L., Boscia, Joseph, Morris, Jason, Huhn, Gregory, Cardona, Jose, Mocherla, Bharat, Stosor, Valentina, Shawa, Imad, Adams, Andrew C., Van Naarden, Jacob, Custer, Kenneth L., Shen, Lei, Durante, Michael, Oakley, Gerard, Schade, Andrew E., Sabo, Janelle, Patel, Dipak R., Klekotka, Paul, Skovronsky, Daniel M.
Formato: Artigo
Idioma:Inglês
Publicado em: Massachusetts Medical Society 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646625/
https://ncbi.nlm.nih.gov/pubmed/33113295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2029849
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados